Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Las: Modulation of insulin secretion by fatty acyl analogs. (0.08 sec) 

Modulation of insulin secretion by fatty acyl analogs


G Las, N Mayorek, K Dickstein, J Bar-Tana - Diabetes, 2006 - Am Diabetes Assoc
The secretagogue, the incretin-like, and the suppressive activities of long-chain fatty acids
(LCFAs) in modulating insulin secretion in vivo and in cultured islets were simulated here by
β,β′-tetramethyl-hexadecanedioic acid (M16) and α,α′-tetrachloro-tetradecanedioic ...
Cited by 3 - Related articles - BL Direct - All 5 versions

Compounds, pharmaceutical compositions and methods for use in treating …


M Akerman, J Houze, DCH Lin, J Liu, J Luo, JC … - US Patent App. 11/ …, 2005 - Google Patents
US 20060004012A1 (19) United States (12) Patent Application Publication (io> Pub. NO.: US
2006/0004012 Al Akerman et al. (43) Pub. Date: Jan. 5,2006 (54) COMPOUNDS, PHARMACEUTICAL
COMPOSITIONS AND METHODS FOR USE IN TREATING METABOLIC DISORDERS ...
Cited by 2 - Related articles - All 8 versions

Effects of aliphatic dioic acids and glycerol-1, 2, 3-tris (dodecanedioate) on D- …


WJ Malaisse, AV Greco, G Mingrone - British Journal of Nutrition, 2007 - Cambridge Univ Press
Page 1. Effects of aliphatic dioic acids and glycerol-1,2,3-tris(dodecanedioate) on D
-glucose-stimulated insulin release in rat pancreatic islets WJ Malaisse 1 *, AV Greco
2 , and G. Mingrone 2 1 Laboratory of Experimental Medicine ...
Cited by 2 - Related articles - BL Direct - All 4 versions

Compounds, pharmaceutical compositions and methods for their use in treating …


J Houze, J Liu, Z Ma, JC Medina, MJ Schmitt, R … - US Patent …, 2008 - Google Patents
Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8. Page 9. Page 10. Page 11.
Page 12. Page 13. Page 14. Page 15. Page 16. Page 17. Page 18. Page 19. Page 20. Page
21. Page 22. Page 23. Page 24. Page 25. Page 26. Page 27. Page 28. Page 29. Page 30. Page ...
Cited by 2 - Related articles - All 6 versions

Peroxisome proliferator-activated receptors as molecular targets in relation to …


O Šeda, L Šedová - Pharmacogenomics, 2007 - Future Medicine
The three isotypes of peroxisome proliferator-activated receptors (PPARs) are currently perceived
as major regulatory nodes (or hubs) of metabolic pathway networks, linking most prevalent diseases
including Type 2 diabetes, obesity, dyslipidemia and atherosclerosis. The integrative ...
Cited by 2 - Related articles - BL Direct - All 4 versions

Glucose regulation in non-insulin-dependent diabetes mellitus: Interaction …


JB Halter, W Kenneth Ward, D Porte… - The American Journal of Medicine, 1985 - Elsevier
The degree of fasting hyperglycemia in patients with non-insulin-dependent diabetes mellitus
is dependent on the rate of hepatic glucose production. The basal rate of hepatic glucose production
is increased in patients with non-insulin-dependent diabetes mellitus, and there is a ...
Cited by 3 - Related articles - All 3 versions

Acute depletion of plasma glutamine increases leucine oxidation in prednisone- …

- nih.gov
O Le Bacquer, N Mauras, S Welch, M Haymond, D … - Clinical Nutrition, 2007 - Elsevier
To determine whether depletion in plasma glutamine worsens the catabolic response to
corticosteroids, seven healthy volunteers received oral prednisone for 6 days on two separate
occasions, at least 2 weeks apart, and in random order. On the sixth day of each ...
Cited by 3 - Related articles - All 21 versions

An overview of genomic data analysis


ES Huang, JR Nevins, M West, PC Kuo - Surgery, 2004 - Elsevier
W ? And, what distinguishes genomics from genetics? Victor McKusick credits his colleague
TH Roderick of the Jackson Laboratory for suggesting the term for a discipline dedicated to studying
groups of genes, or entire genomes, as opposed to the study of individual genes that ...
Cited by 3 - Related articles - All 9 versions

Diabetes: the latest developments in inhibitors, insulin sensitisers, new drug targets …


CM Rondinone - Expert opinion on therapeutic targets, 2005 - 万方数据资源系统
The 6th annual conference on diabetes, organised by the SMI group, was held on 18th - 19th
October 2004 in London, followed by a one-day symposium on an executive briefing entitled
Type 2 diabetes and beyond: the untapped commercial potential. More than 100 ...
Cited by 3 - Related articles - All 3 versions

Acute administration of GPR40 receptor agonist potentiates glucose-stimulated …


LS Doshi, MK Brahma, SG Sayyed, AV Dixit, … - Metabolism: clinical …, 2009 - ncbi.nlm.nih.gov
Recently, several in vitro studies have shown that GPR40 receptor activation by free fatty acids
(FFAs) results in glucose-dependent insulin secretion. However, whether GPR40 receptor activation
results in glucose-dependent insulin secretion in vivo in rats is not known. Therefore, we ...
Cited by 3 - Related articles - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google